Clinical trial
Synaptic Mechanisms of Intermittent Theta Burst Stimulation for Major Depressive Disorder
NCT07593222 is registered in ClinicalTrials.gov with Mclean Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Synaptic Mechanisms of Intermittent Theta Burst Stimulation for Major Depressive Disorder
- Lead sponsor
- Mclean Hospital
- Phase
- Phase 1/2
- Overall status
- Not yet recruiting
- Start date
- September 1, 2026
- Completion date
- June 30, 2031
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy participants, major depression